More than 60 patients groups yesterday urged Congress to protect the 340B drug savings program. “We stand together to oppose any efforts to diminish the 340B program’s proven ability to help serve vulnerable patients and communities,” wrote the groups. “340B is vital to the health care safety net as it enables trusted community providers to fulfill their missions. In many communities – particularly low-income rural and urban areas – safety net providers are the sole pathways to affordable health care.”

Headline
The Health Resources and Services Administration Feb. 25 said it will extend the deadline to April 20 to receive comments on its request for information on…
Headline
The U.S. District Court for the District of Hawaii Feb. 23 denied a preliminary injunction requested by AstraZeneca in a case challenging the state’s law…
Headline
The AHA, joined by several other national groups representing 340B hospitals, Feb. 19 urged the Health Resources and Services Administration to extend the…
Headline
The Minnesota Court of Appeals Feb. 17 affirmed a lower court decision in ruling that the state’s 340B contract pharmacy law is not preempted by federal law.…
Headline
The Department of Health and Human Services Feb. 13 issued a request for information on a new 340B rebate model program. The RFI said HHS’ Health Resources and…
Headline
The House Energy and Commerce Subcommittee on Health Feb. 11 hosted a hearing titled “Lowering Health Care Costs for All Americans: An Examination of the…